SEA4US
A world-class biotechnology company in marine pharmaceutical research and development that aims to discover treatments to respond to unmet clinical needs.
Proud Member of EARA
Taking our non-opioid analgesic to clinical trials: Sea4Market has started
Sea4Market is starting, taking our first in class non-opioid analgesic for the treatment of chronic pain to clinical trials in 2025.
Chronic pain affects 1.6 billion people worldwide, which have either ineffective or unsafe treatments available.
Our marine-inspired novel analgesic allows safe and effective treatment, without the associated serious side-effects seen with most available solutions, such as opioids.
Funding through the Accelerator Program from the European Innovation Council and SMEs Executive Agency (EISMEA), Project number 101145231.
Check out our LinkedIn update here.
#Biotechnology #DrugDevelopment #ChronicPain #NonOpioid #EicAccelerator
